Takeda to invest €40M, create 40 jobs in new Dublin facility: 4 things to know

Japan’s Takeda Pharmaceuticals is investing €40 million into a new high-containment production center in Dublin, Ireland, The Irish Times reports.

Advertisement

Here’s what you should know.

1. The facility will create 40 new jobs in the capital of Ireland.

2. Takeda will manufacture Ninlargo, an oncology prescription, out of the new site.

3. Takeda started operating out of Dublin in 1997. It employs 400 at three sites in the city.

4. Plant Director at Takeda Ireland Grange Castle Paul Keogh said Takeda made the decision based on the success of its other Irish branches.

More articles on healthcare:
7 things for ASC leaders to know for Monday — Dec. 5, 2016
Dr. Segun Ishmael founded STI treatment app: 4 key notes
20 ASCs and endoscopy centers with prices posted online 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.